Navidea biopharmaceuticals to ring opening bell at the new york stock exchange

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that members of navidea’s executive leadership team and board of directors will ring the opening bell® at the new york stock exchange (nyse) on tuesday, september 29, 2020. “this is a very proud day for the navidea team as we approach the launch of the next phase of ou
NAVB Ratings Summary
NAVB Quant Ranking